Live feed
Filing
SC 13G/A
SC 13G/A0000930413-17-000524·MERRIMACK PHARMACEUTICALS INC
Schedule 13G ownership disclosure
MERRIMACK PHARMACEUTICALS INC
Security class unavailable · CUSIP: 590328100
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,403,594
- Percent of class
- 4.9400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000930413-17-000524
- Form type
- SC 13G/A
- Filer
- MERRIMACK PHARMACEUTICALS INC
- CIK
- CIK 1274792
- Filed
- Feb 14, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership